Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T De Paulis

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
M-100907 (Aventis)T de Paulis
Synapse (New York, N.Y.)|November 1, 1993
Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamideJ R Votaw, R M Kessler, T de Paulis
Arzneimittel-Forschung|January 1, 1981
Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolitesJ Lundström, T Högberg, T Gosztonyi, et al.
Journal of Medicinal Chemistry|February 1, 1990
Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agentsD A Davis, T de Paulis, A Janowsky, et al.
Journal of Medicinal Chemistry|October 1, 1989
Sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agentsJ H Rupard, T de Paulis, A Janowsky, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamidesD E Schmidt, J R Votaw, R M Kessler, et al.
Molecular Pharmacology|October 1, 1986
Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor modelsT Högberg, S Rämsby, T de Paulis, et al.
Journal of Medicinal Chemistry|October 1, 1988
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptorsT de Paulis, A Janowsky, R M Kessler, et al.
Brain Research|October 20, 1999
Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfateA Zuckerman, E Bolan, T de Paulis, et al.
Journal of Medicinal Chemistry|August 1, 1990
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative studyT Högberg, T de Paulis, L Johansson, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
M-100907 (Aventis)T de Paulis
Synapse (New York, N.Y.)|November 1, 1993
Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamideJ R Votaw, R M Kessler, T de Paulis
Arzneimittel-Forschung|January 1, 1981
Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolitesJ Lundström, T Högberg, T Gosztonyi, et al.
Journal of Medicinal Chemistry|February 1, 1990
Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agentsD A Davis, T de Paulis, A Janowsky, et al.
Journal of Medicinal Chemistry|October 1, 1989
Sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agentsJ H Rupard, T de Paulis, A Janowsky, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]-substituted benzamidesD E Schmidt, J R Votaw, R M Kessler, et al.
Molecular Pharmacology|October 1, 1986
Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor modelsT Högberg, S Rämsby, T de Paulis, et al.
Journal of Medicinal Chemistry|October 1, 1988
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptorsT de Paulis, A Janowsky, R M Kessler, et al.
Brain Research|October 20, 1999
Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfateA Zuckerman, E Bolan, T de Paulis, et al.
Journal of Medicinal Chemistry|August 1, 1990
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative studyT Högberg, T de Paulis, L Johansson, et al.
Pageof 4